ISCHEMIC STROKE AS FIRST MANIFESTATION OF ESSENTIAL THROMBOCYTHEMIA - REPORT OF 6 CASES

被引:49
作者
ARBOIX, A [1 ]
BESSES, C [1 ]
ACIN, P [1 ]
MASSONS, JB [1 ]
FLORENSA, L [1 ]
OLIVERES, M [1 ]
SANSSABRAFEN, J [1 ]
机构
[1] HOSP BARCELONA LALIANCA,HEMATOL & ONCOL UNIT 1973,BARCELONA,SPAIN
关键词
CEREBRAL ISCHEMIA; MYELOPROLIFERATIVE DISORDERS; DIAGNOSIS; THROMBOCYTHEMIA; HEMORRHAGIC;
D O I
10.1161/01.STR.26.8.1463
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Ischemic stroke as a presenting sign of essential thrombocythemia has been infrequently reported. We describe six patients in whom cerebrovascular disease was the first manifestation of this myeloproliferative disease. A positive endogenous megakaryocyte and/or erythroid colony growth from blood was a diagnostic criterion of essential thrombocythemia in patients with platelets counts lower than 600 x 10(9)/L. Case Descriptions These six patients represented 0.54% of all patients with first stroke, 42.8% of all hematologic disorders associated with stroke, and 12.5% of all patients with essential thrombocythemia diagnosed from 1986 to 1992 at our institution. Eleven acute cerebrovascular accidents (6 transient ischemic attacks, 5 definitive cerebral infarcts) were registered. Mean time from ischemic stroke to diagnosis of essential thrombocythemia was 4.5 months (range, 1 to 12 months). The mean platelet count was 597 x 10(9)/L (range, 414 to 760 x 10(9)/L). Four patients had platelets counts lower than 600 x 10(9)/L. All patients had circulating erythroid progenitors, megakaryocytic progenitors, or both. Conclusions Ischemic stroke as a presenting manifestation of essential thrombocythemia is probably underrecognized. The diagnosis of thrombocythemia should not be excluded on the basis of platelet counts lower than 600 x 10(9)/L. The availability of in vitro culture of hematopoietic progenitors from peripheral blood makes it possible to diagnose early and atypical cases.
引用
收藏
页码:1463 / 1466
页数:4
相关论文
共 19 条
[1]   STROKE IN A TERTIARY HOSPITAL IN SAUDI-ARABIA - A STUDY OF 372 CASES [J].
ALRAJEH, S ;
LARBI, E ;
BADEMOSI, O ;
AWADA, A ;
ISMAIL, H ;
ALFREIHI, H ;
ALGHASSAB, G .
EUROPEAN NEUROLOGY, 1991, 31 (04) :251-256
[2]  
ARBOIX A, 1993, MED CLIN-BARCELONA, V101, P281
[3]  
BERNAD PG, 1978, STROKE, V9, P110
[4]   THE LAUSANNE STROKE REGISTRY - ANALYSIS OF 1,000 CONSECUTIVE PATIENTS WITH 1ST STROKE [J].
BOGOUSSLAVSKY, J ;
VANMELLE, G ;
REGLI, F .
STROKE, 1988, 19 (09) :1083-1092
[5]   HYDROXYUREA FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND A HIGH-RISK OF THROMBOSIS [J].
CORTELAZZO, S ;
FINAZZI, G ;
RUGGERI, M ;
VESTRI, O ;
GALLI, M ;
RODEGHIERO, F ;
BARBUI, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) :1132-1136
[6]   INCIDENCE AND RISK-FACTORS FOR THROMBOTIC COMPLICATIONS IN A HISTORICAL COHORT OF 100 PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA [J].
CORTELAZZO, S ;
VIERO, P ;
FINAZZI, G ;
DEMILIO, A ;
RODEGHIERO, F ;
BARBUI, T .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :556-562
[7]  
FLORENSA L, 1995, LEUKEMIA, V9, P271
[8]  
FLORENSA L, 1989, EUR J HAEMATOL, V43, P417
[9]   HEMATOLOGIC DISORDERS AND ISCHEMIC STROKE - A SELECTIVE REVIEW [J].
HART, RG ;
KANTER, MC .
STROKE, 1990, 21 (08) :1111-1121
[10]   ERYTHROID COLONY FORMATION IN CULTURES OF MOUSE AND HUMAN BONE-MARROW - ANALYSIS OF REQUIREMENT FOR ERYTHROPOIETIN BY GEL-FILTRATION AND AFFINITY CHROMATOGRAPHY ON AGAROSE-CONCANAVALIN-A [J].
ISCOVE, NN ;
SIEBER, F ;
WINTERHALTER, KH .
JOURNAL OF CELLULAR PHYSIOLOGY, 1974, 83 (02) :309-320